ARMISTICE CAPITAL, LLC - STRONGBRIDGE BIOPHARMA PLC ownership

STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 19 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 4.5%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q2 2019$4,945,000
-60.2%
1,580,000
-36.6%
0.31%
-54.1%
Q1 2019$12,410,000
-3.7%
2,492,000
-13.4%
0.68%
-30.5%
Q4 2018$12,893,000
+0.3%
2,878,000
+8.6%
0.98%
+26.6%
Q3 2018$12,853,000
-0.7%
2,650,000
+22.8%
0.77%
-8.7%
Q2 2018$12,948,000
-56.6%
2,158,000
-36.0%
0.85%
-62.9%
Q1 2018$29,842,000
+43.4%
3,372,000
+17.5%
2.28%
+10.0%
Q4 2017$20,808,000
+78.0%
2,870,000
+69.4%
2.08%
+50.7%
Q3 2017$11,693,000
-3.3%
1,694,600
+0.2%
1.38%
-10.7%
Q2 2017$12,098,000
+55.3%
1,692,000
+3.2%
1.54%
-4.2%
Q1 2017$7,790,0001,640,0001.61%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q1 2017
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 978,907$6,865,0003.28%
RA Capital Management 2,690,702$20,449,0002.02%
NEA Management Company, LLC 2,141,308$16,274,0001.04%
Broadfin Capital, LLC 1,656,705$10,911,0000.67%
Tredje AP-fonden 909,581$6,913,0000.44%
Granite Point Capital Management, L.P. 388,945$2,679,0000.40%
Ghost Tree Capital, LLC 72,726$553,0000.23%
SPHERA FUNDS MANAGEMENT LTD. 181,818$1,382,0000.20%
Tower Research Capital LLC (TRC) 1,094$8,0000.00%
ACADIAN ASSET MANAGEMENT LLC 1,373$10,0000.00%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders